問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of General Surgery

Division of Pediatrics

更新時間:2023-09-19

許文明
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

5Cases

2020-06-01 - 2026-10-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2021-12-31 - 2024-06-30

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2018-03-18 - 2024-10-31

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2021-12-31 - 2024-06-30

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2020-06-01 - 2026-10-30

Phase III

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Odevixibat (A4250) in Children With Biliary Atresia Who Have Undergone a Kasai Hepatoportoenterostomy
  • Condition/Disease

    biliary atresia

  • Test Drug

    Odevixibat (A4250)

Participate Sites
2Sites

Recruiting2Sites